{"id":"oxyclipine","rwe":[],"tags":[{"label":"oxyclipine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"delinal","offLabel":[],"synonyms":["propenzolate hydrochloride","propenzolate HCl","delinal","NDR 263","propenzolate","oxyclipine"],"timeline":[],"approvals":[],"brandName":"Delinal","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"oxyclipine","explanation":"Imagine Delinal as a key that fits into a lock in the body. When it binds to the lock, it triggers a series of events that ultimately lead to the desired outcome, such as reducing symptoms of a particular disease or condition.","oneSentence":"Delinal works by interacting with a specific target in the body to produce a desired therapeutic effect.","technicalDetail":"Delinal is a small molecule oxyclipine that likely exerts its effects through a specific interaction with a protein or receptor in the body, although the exact mechanism of action is not well-documented."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3821","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=oxyclipine","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:13:47.260877","biosimilars":[],"competitors":[],"genericName":"oxyclipine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"YCZ9J99C72","CHEBI":"CHEBI:135414","INN_ID":"1334","UMLSCUI":"C5418520","ChEMBL_ID":"CHEMBL2111025","PUBCHEM_CID":"14991","SECONDARY_CAS_RN":"1420-03-7"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Delinal (oxyclipine) is a small molecule oxyclipine with unknown target and commercial status. Its mechanism of action is not well-documented, and it has not been approved by the FDA for any indications. As a result, there is limited information available on its pharmacokinetics, safety, and efficacy. Further research is needed to fully understand Delinal's potential as a therapeutic agent. Its development status and patent status are also unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}